Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ASBP will decline by -100.00% over the next 2 Weeks and hit $0.00 by Tuesday, May 26, 2026. In that time frame, ASBP's share price is expected to range between $0.00 and $7.74.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 26, 2026 | 0.00 | 0.00 | 7.74 |
| May 25, 2026 | 0.00 | 0.00 | 8.19 |
| May 22, 2026 | 0.00 | 0.00 | 6.19 |
| May 21, 2026 | 0.00 | 0.00 | 7.30 |
| May 20, 2026 | 0.00 | 0.00 | 8.98 |
| May 19, 2026 | 0.00 | 1.14 | 11.49 |
| May 18, 2026 | 0.00 | 1.66 | 11.29 |
| May 15, 2026 | 0.00 | 0.00 | 10.24 |
| May 14, 2026 | 0.00 | 0.58 | 11.24 |
| May 13, 2026 | 0.00 | 2.82 | 13.42 |
ASBP shares rose +4.45% in Wednesday, May 13, 2026's trading session, rising from a previous close of $5.17 to move at $5.40. The stock demonstrated notable intraday movement (see ASBP's key stats for a full breakdown), fluctuating between $5.01 and $5.44, a +8.58% trading range. While recent weeks have seen some volatility, ASBP has managed to secure a -13.75% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 166.09K shares changing hands, 79.05K fewer than the previous session. This amounted to $896.86K in total market activity.
Will ASBP Continue Its Upward Trend?
According to analyst ratings and projections for ASBP, Aspire Biopharma Holdings, Inc. shares are anticipated to increase by +30.27%, potentially reaching $7.74 per share by May 26, 2026. Short-term technical indicators for ASBP currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the ASBP stock forecast, now is a good time to buy ASBP stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on ASBP covering social and institutional perspectives.
ASBP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ASBP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 30.87% to 33.32%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 37.05%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 36.05%, signals a bearish bias in the long-term trend. Insights into ASBP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Aspire Biopharma Short-Term Forecasts
ASBP Forecast For Next 5 Days
Our algorithm anticipates Aspire Biopharma (ASBP) stock could hit $4.00 by May 20, 2026. This represents a -25.95% fall from today's price, following a -47.11% change over the past five days.
ASBP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Aspire Biopharma Holdings, Inc. (ASBP) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.08, which would mean a -42.96% decrease from the current price of $5.40. Projections for this period range from a high of $12.95 to a low of $0.00.
ASBP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Aspire Biopharma's price over the next three months point to a drop. ASBP stock is expected to peak at $74.89 on May 13, 2026 before potentially dipping to $0.00 on Aug 13, 2026. On average, ASBP is likely to trade around $5.11 in the coming 90 days.
Aspire Biopharma Stock Forecast 2025
Based on our predictive models, Aspire Biopharma (ASBP) is expected to trade between $0.00 and $74.89 throughout 2026. This would result in an average price of $3.20, potentially offering investors a -40.74% return from current levels.
Aspire Biopharma Holdings, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Aspire Biopharma Holdings, Inc. (ASBP) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.00 and $74.89, settling at an average of $5.21. This could translate to a -3.52% loss.
June 2026
Based on current market signals, Aspire Biopharma Holdings, Inc. is projected to trend june 2026. We forecast a trading range from $0.00 to $65.58, with a likely average price of $6.69. Investors could expect a potential return of +23.89%.
July 2026
Our predictive algorithms indicate Aspire Biopharma Holdings, Inc. stock may see a shift in July 2026. The expected range spans $0.00–$61.93, with an average target of $3.80. This represents a cautious outlook and a possible loss of -29.63%.
August 2026
Analyzing established trends, Aspire Biopharma Holdings, Inc. looks set to move in August 2026. Projections place the stock between $0.00 and $66.88, averaging around $4.81. This suggests a -10.93% loss from current levels.
September 2026
Market indicators suggest Aspire Biopharma Holdings, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $70.30, with a midpoint forecast of $3.01. The stock might deliver a -44.26% loss.
October 2026
Forecasting for October 2026, models estimate that Aspire Biopharma Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $64.24, averaging $1.85. This signals a cautious trajectory with potential returns around -65.74%.
November 2026
According to our latest forecast models, Aspire Biopharma Holdings, Inc. (ASBP) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $64.77, settling at an average of $0.72. This could translate to a -86.67% loss.
December 2026
Based on current market signals, Aspire Biopharma Holdings, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $59.73, with a likely average price of $0.38. Investors could expect a potential return of -92.96%.
January 2027
Our predictive algorithms indicate Aspire Biopharma Holdings, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$69.04, with an average target of $0.32. This represents a cautious outlook and a possible loss of -94.07%.
February 2027
Analyzing established trends, Aspire Biopharma Holdings, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $62.32, averaging around $0.34. This suggests a -93.70% loss from current levels.
March 2027
Market indicators suggest Aspire Biopharma Holdings, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $59.47, with a midpoint forecast of $0.05. The stock might deliver a -99.07% loss.
April 2027
Forecasting for April 2027, models estimate that Aspire Biopharma Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $63.73, averaging $0.03. This signals a cautious trajectory with potential returns around -99.44%.
May 2027
According to our latest forecast models, Aspire Biopharma Holdings, Inc. (ASBP) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $62.77, settling at an average of $0.03. This could translate to a -99.44% loss.
ASBP's history of dividends and stock splits also plays a role in long-term investor confidence.